ARTICLE
NEWS RELEASE – For Immediate Release For more information contact: Michele Chynoweth, Marketing Specialist Email: [email protected] Phone: 302-656-7905 BIRD Foundation Virtual Lunch & Learn on U.S.- Israel Joint Project Funding Opportunities a Big Success New Castle, DE, 2021—The BIRD Foundation virtual Lunch & Learn event on July 1 attracted dozens of business owners who were afforded the opportunity to learn about funding for joint projects between U.S. and Israeli businesses and hear from leaders of a successful funding recipient from Delaware. A Delaware based BIRD project case study will also be presented by Eric B. Kmiec, Ph.D., Director, Gene Editing Institute of Christiana Care’s Helen F. Graham Cancer Center & Research Institute. The Institute was awarded a $900,000 BIRD grant with Israeli biotechnology company Fore Biotherapeutics, formally known as NovellusDx; the companies co-developed new gene editing technologies that help identify the genetic mechanism responsible for both the onset and progression of many types of cancer. “Without the BIRD grant we wouldn’t have been able to go from research to commercialization,” Eric Kmiec said, adding that a lot of other benefits occurred as a result of the gran. “It isn’t just the money you get or that your product goes into development, but some other very good things can happen.” He referred to future innovation being considered by the joint partnership and educational programs for high school and college students that resulted from the BIRD project. Andrea Yonah, Director of Business Development, East Coast & Midwest BIRD Foundation, said the foundation is looking to back innovative projects that have “complementary technology” and “sound commercial strategies to get that technology to market.” She said proposals will be due in September and awarded in December. The program also featured Vered Nohi, Executive Director, Philadelphia-Israel Chamber of Commerce and Representative for PA, DE and SNJ BIRD Foundation, Michael Fleming, President, Delaware BioScience Association and World Trade Center Delaware President Carla Stone. Annually, the U.S.-Israel Binational Industrial Research and Development (BIRD) Foundation approves 20-25 grants of up to a $1 million each (with the potential for up to $1.5 million for exceptional proposals) for the co-development of innovative products, technologies or milestone-based pharma projects. BIRD takes no IP or equity. The virtual event is co-hosted by the Philadelphia-Israel Chamber of Commerce, the representative of the US-Israel Binational Industrial Research and Development (BIRD) Foundation in Pennsylvania, Delaware and Southern New Jersey, the World Trade Center Delaware and the Delaware BioScience Association. BIRD’s scope extends to Advanced Manufacturing, Agrotechnology, Cleantech and Environment, Communications, Construction Tech, Electronics, FinTech, Gas, Healthcare IT, Homeland Security and Cyber Security, Life Sciences and Bio-Convergence, Software, Water and Wastewater technologies, etc. and other technology sectors.
NEWS RELEASE – For Immediate Release For more information contact: Michele Chynoweth, Marketing Specialist Email: [email protected] Phone: 302-656-7905
BIRD Foundation Virtual Lunch & Learn on U.S.- Israel Joint Project Funding Opportunities a Big Success
New Castle, DE, 2021—The BIRD Foundation virtual Lunch & Learn event on July 1 attracted dozens of business owners who were afforded the opportunity to learn about funding for joint projects between U.S. and Israeli businesses and hear from leaders of a successful funding recipient from Delaware. A Delaware based BIRD project case study will also be presented by Eric B. Kmiec, Ph.D., Director, Gene Editing Institute of Christiana Care’s Helen F. Graham Cancer Center & Research Institute. The Institute was awarded a $900,000 BIRD grant with Israeli biotechnology company Fore Biotherapeutics, formally known as NovellusDx; the companies co-developed new gene editing technologies that help identify the genetic mechanism responsible for both the onset and progression of many types of cancer. “Without the BIRD grant we wouldn’t have been able to go from research to commercialization,” Eric Kmiec said, adding that a lot of other benefits occurred as a result of the gran. “It isn’t just the money you get or that your product goes into development, but some other very good things can happen.” He referred to future innovation being considered by the joint partnership and educational programs for high school and college students that resulted from the BIRD project. Andrea Yonah, Director of Business Development, East Coast & Midwest BIRD Foundation, said the foundation is looking to back innovative projects that have “complementary technology” and “sound commercial strategies to get that technology to market.” She said proposals will be due in September and awarded in December. The program also featured Vered Nohi, Executive Director, Philadelphia-Israel Chamber of Commerce and Representative for PA, DE and SNJ BIRD Foundation, Michael Fleming, President, Delaware BioScience Association and World Trade Center Delaware President Carla Stone. Annually, the U.S.-Israel Binational Industrial Research and Development (BIRD) Foundation approves 20-25 grants of up to a $1 million each (with the potential for up to $1.5 million for exceptional proposals) for the co-development of innovative products, technologies or milestone-based pharma projects. BIRD takes no IP or equity. The virtual event is co-hosted by the Philadelphia-Israel Chamber of Commerce, the representative of the US-Israel Binational Industrial Research and Development (BIRD) Foundation in Pennsylvania, Delaware and Southern New Jersey, the World Trade Center Delaware and the Delaware BioScience Association. BIRD’s scope extends to Advanced Manufacturing, Agrotechnology, Cleantech and Environment, Communications, Construction Tech, Electronics, FinTech, Gas, Healthcare IT, Homeland Security and Cyber Security, Life Sciences and Bio-Convergence, Software, Water and Wastewater technologies, etc. and other technology sectors.